Updated: September 29, 2023
Re-exam No. | Patent No. | Request Date | Certificate Mailed Date/Status |
---|---|---|---|
RX-1/90 | 1,271,207 | September 4, 1990 | April 14, 1992 |
RX-2/90 | 1,264,107 | September 21, 1990 | May 12, 1992 |
RX-3/90 | 1,272,996 | December 21, 1990 | July 20, 1992 |
RX-4/91 | 1,269,028 | February 28, 1991 | June 1, 1992 |
RX-5/91 | 1,278,701 | September 19, 1991 | August 24, 1992 |
RX-6/92 | 1,285,109 | June 23, 1992 | December 14, 1993 |
RX-7/93 | 1,248,930 | September 24, 1993 | Fee Refunded February 10, 1994. Patent Law not applicable. |
RX-8/94 | 1,311,707 | February 8, 1994 | October 20, 1994 |
RX-9/95 | 1,307,051 | February 8, 1995 | Terminated by the Board. No substantial new question raised. Letter mailed May 9, 1995. |
RX-10/95 | 1,286,855 | May 18, 1995 | July 29, 1996 |
RX-11/95 | 1,324,237 | May 30, 1995 | August 8, 1996 |
RX-12/95 | 2,067,683 | June 9, 1995 | July 5, 1996 |
RX-13/96 | 1,324,237 | March 8, 1996 | Terminated by the Board. No substantial new question has been raised. Letter mailed August 8, 1996. |
RX-14/96 | 1,286,855 | April 23, 1996 | Terminated by the Board. No substantial new question has been raised. Letter mailed July 24, 1996. |
RX-15/96 | 2,101,884 | April 19, 1996 May 3, 1996 Amendment |
Terminated by the Board. No substantial new question has been raised. Letter mailed September 3, 1996. |
RX-16/96 | 2,049,534 | May 22, 1996 | January 14, 1997 |
RX-17/97 | 1,321,525 | April 14, 1997 | October 30, 1998 |
RX-18/97 | 2,057,644 | May 16, 1997 | June 17, 1998 |
RX-19/97 | 2,105,636 | July 16, 1997 | July 22, 1998 |
RX-20/98 | 1,319,072 | March 12, 1998 | March 18, 1999 |
RX-21/99 | 2,086,794 | March 31, 1999 | November 8, 2000 |
RX-22/99 | 2,086,730 | December 6, 1999 | November 7, 2000 |
RX-23/99 | 2,070,274 | December 14, 1999 | Patent lapsed on June 2 2000 for failure to pay the required maintenance fee. Letter mailed July 6, 2000. |
RX-24/00 | 2,204,977 | October 8, 2000 | August 21, 2001/Cancelled. New one issued February 6, 2002. |
RX-25/01 | 2,041,521 | May 9, 2001 | Terminated by the Board. No substantial new question has been raised. Letter mailed May 9, 2001. |
RX-26/01 | 2,130,471 | March 27, 2001 | January 31, 2003 |
RX-27/02 | 1,216,871 | April 4, 2002 | Not open to re-examination - Old Act. |
RX-28/03 | 2,136,053 | January 13, 2003 | July 20, 2004 |
RX-29/03 | 2,145,542 | January 2, 2003 | November 10, 2003 |
RX-30/03 | 2,147,706 | May 21, 2003 | October 25, 2004 |
RX-31/03 | 2,148,521 | June 24, 2003 | September 29, 2004 |
RX-32/03 | 2,249,513 | July 7, 2003 | May 12, 2004 |
RX-33/04 | 2,093,422 | May 1, 2004 | November 16, 2005 |
RX-34/04 | 2,360,005 | June 3, 2004 | Terminated by the Board. No substantial new question has been raised. Letter mailed October 27, 2004. |
RX-35/04 | 2,143,685 | July 7, 2004 | February 21, 2006 |
RX-36/04 | 2,254,284 | July 9, 2004 | September 30, 2005 |
RX-37/05 | 2,187,474 | January 25, 2005 | November 16, 2005 |
RX-38/05 | 2,364,968 | July 19, 2005 | Terminated by the Board. No substantial new question of patentability. Letter mailed November 15, 2005 |
RX-39/05 | 2,348,328 | July 19, 2005 | Terminated by the Board. No substantial new question of patentability. Letter mailed November 15, 2005. |
RX-40/05 | 2,115,751 | August 4, 2005 | February 28, 2007 |
RX-41/05 | 2,188,870 | October 11, 2005 | September 26, 2006 |
RX-42/05 | 2,189,029 | October 11, 2005 | September 26, 2006 |
RX-43/05 | 2,300,818 | October 11, 2005 | September 14, 2006 |
RX-44/06 | 2,258,339 | February 3, 2006 | March 12, 2007 |
RX-45/06 | 2,002,806 | February 21, 2006 | July 17, 2007 |
RX-46/06 | 2,233,265 | August 14, 2006 | September 19, 2007 |
RX-47/07 | 2,364,613 | March 21, 2007 | Terminated by the Board. No substantial new question of patentability has been raised. Letter mailed June 1, 2007. |
RX-48/07 | 2,373,527 | August 29, 2007 | Terminated by the Board. This request is not admissible under Subsection 48.1(2) of the Patent Act |
RX-49/07 | 2,456,455 | August 31, 2007 | March 13, 2009 |
RX-50/07 | 2,359,812 | October 30, 2007 | Terminated by the Board. No substantial new question of patentability has been raised. Letter mailed February 15, 2008. |
RX-51/08 | 2,373,527 | July 23, 2008 | April 3, 2009 |
RX-52/08 | 2,425,162 | August 6, 2008 | October 1, 2009 |
RX-53/08 | 2,458,284 | September 9, 2008 | January 18, 2010 |
RX-54/08 | 2,450,774 | September 19, 2008 | Terminated by the Board. No substantial new question of patentability has been raised. Letter mailed March 2, 2009. |
RX-55/08 | 2,489,738 | November 18, 2008 | Terminated by the Board. No substantial new question of patentability. Letter mailed April 28, 2009. |
RX-56/08 | 2,188,746 | November 27, 2008 | November 5, 2010 |
RX-57/09 | 2,084,013 | December 11, 2008 | Court ordered stay on January 8 2010. In accordance with the direction received from the Federal Court dated August 7, 2012, the stay remains in force and has the effect of terminating the re-examination. The Board will not take further action in respect of this case. |
RX-58/09 | 2,464,983 | September 8, 2009 | Terminated by the Board. No substantial new question of patentability. Letter mailed December 22, 2009. |
RX-59/09 | 2,107,134 | October 14, 2009 | Terminated by the Board. No substantial new question of patentability. Letter mailed March 10, 2010. |
RX-60/10 | 2,668,777 | May 6, 2010 | September 27, 2011 |
RX-61/10 | 2,668,777 | April 16, 2010 | September 27, 2011 |
RX-62/11 | 2,210,450 | November 24, 2010 | Terminated by the Board. No substantial new question of patentability. Letter mailed June 14, 2011. |
RX-63/11 | 2,575,080 | December 14, 2010 | Terminated by the Board. No substantial new question of patentability. Letter mailed June 27, 2011. |
RX-64/11 | 2,465,538 | March 10 2011 | Terminated by the Board. Request not admissible under subsection 48.1(2) of the Patent Act. Letter mailed March 29, 2011. |
RX-65/11 | 2,448,699 | February 2, 2011 | Decembernbsp;8, 20, 11 |
RX-66/11 | 2,550,749 | April 18, 2011 | Terminated by the Board. No substantial new question of patentability. The submitted prior art does not render these claims anticipated or obvious. Letter mailed June 30, 2011. |
RX-67/11 | 2,421,384 | August 15, 2011 | October 29, 2012 |
RX-68/11 | 2,465,538 | July 8, 2011 | Terminated by the Board. No substantial new question of patentability has been raised. Letter mailed December 16, 2011. |
RX-69/11 | 2,556,685 | October 7, 2011 | April 17, 2012 |
RX | 2,193,519 | January 10, 2012 | April 26, 2013 |
RX-71/12 | 2,230,262 | April 3, 2012 | May 21, 2013 |
RX-72/12 | 2,124,963 | June 29, 2012 | June 26, 2013 |
RX-73/12 | 2,134,617 | July 26, 2012 | Terminated by the Board. No substantial new question of patentability. Letter mailed January 15, 2013. |
RX-74/12 | 2,219,513 | November 21, 2012 | October 7, 2013 |
RX-75/12 | 2,604,280 | November 21, 2012 | August 29, 2013 |
RX-76/13 | 2,735,347 | February 8, 2013 | November 5, 2013 |
RX-77/13 | 2,420,949 | May 10, 2013 | December 22, 2014 |
RX-78/13 | 2,381,165 | June 14, 2013 | October 22, 2014 |
RX-79/13 | 2,452,515 | September 3, 2013 | Terminated by the Board. No substantial new question of patentability. Letter mailed February 6, 2014. |
RX-80/14 | 2,635,852 | January 14, 2014 | October 1, 2014 |
RX-81/14 | 2,657,861 | January 27, 2014 | March 12, 2015 |
RX-82/14 | 2,388,294 | February 26, 2014 | November 19, 2014 |
RX-83/14 | 2,607,375 | May 1, 2014 | April 28, 2017 |
RX-84/14 | 2,599,773 | December 12, 2014 | July 20, 2016 |
RX-85/15 | 2,810,121 | January 23, 2015 | September 21, 2016 |
RX-86/15 | 2,687,802 | January 8, 2015 | July 20, 2016. |
RX-87/15 | 2,746,152 | April 16, 2015 | Terminated by the Board. No substantial new question of patentability. Letter mailed September 11, 2015. |
RX-88/15 | 2,797,761 | May 4, 2015 | October 24, 2016 |
RX-89/15 | 2,755,824 | August 18, 2015 | Terminated. Not a proper request. Letter mailed October 5, 2015. |
RX-90/15 | 2,708,890 | September 11, 2015 | February 22, 2017 |
RX-91/15 | 2,738,767 | September 11 2015 | February 22, 2017 |
RX-92/15 | 2,743,603 | September 11, 2015 | February 22, 2017 |
RX-93/15 | 2,778,555 | December 18, 2015 | August 11, 2017 |
RX-94/15 | 2,822,562 | December 24, 2015 | Court ordered stay of re-exam October 6, 2016. |
RX-95/15 | 2,600,215 | December 31, 2015 | Terminated. No substantial new question of patentability. Letter mailed June 3, 2016. |
RX-96/16 | 2,788,206 | January 15, 2016 | June 29, 2017 |
RX-97/16 | 2,729,619 | February 22, 2016 | Terminated. Not a proper request. Letter mailed April 22, 2016. |
RX-98/16 | 2,233,739 | March 21, 2016 | September 20, 2017 |
RX-99/16 | 2,729,619 | August 5, 2016 | November 30, 2017 |
RX-100/17 | 2,876.770 | January 25, 2017 | July 13, 2018 |
RX-101/17 | 2,719,528 | May 16, 2017 | September 25, 2017 |
RX-102/17 | 2,381,165 | May 12, 2017 | April 17, 2018 |
RX-103/17 | 2,340,185 | June 22, 2017 | December 21, 2018 |
RX-104/17 | 2,723,630 | June 22, 2017 | October 1, 2019 |
RX-105/17 | 2,751,174 | June 27, 2017 | Terminated. No substantial new question of patentability. Letter mailed October 20, 2017. |
RX-106/17 | 2,782,487 | July 19, 2017 | December 21, 2018 |
RX-107/17 | 2.699.556 | October 17, 2017 | June 15, 2018 |
RX-108/17 | 2.755,824 | October 2, 2017 | February 21, 2019 |
RX-109/17 | 2,753,273 | December 19, 2017 | August 7, 2019 |
RX-110/17 | 2,818,250 | December 21, 2017 | July 26, 2019 |
RX-111/18 | 2,902,498 | January 12, 2018 | November 30, 2018 |
RX-112/18 | 2,704,692 | February 20, 2018 | Terminated. No substantial new question of patentability. Letter mailed June 1, 2018. |
RX-113/18 | 2,871,354 | February 23, 2018 | June 12, 2019 |
RX-114/18 | 2,383,341 | March 9, 2018 | Fee missing. Letter mailed March 22 ,2018. Patent deemed expired on August 31, 2020. |
RX-115/18 | 2.909,296 | April 4, 2018 | May 3, 2019 |
RX-116/18 | 2,867,736 | March 29, 2018 | October 10, 2019 |
RX-117/18 | 2,871,354 | May 2, 2018 | June 12, 2019 |
RX-118/18 | 2,691,324 | June 22, 2018 | Terminated. No substantial new question of patentability. Letter mailed October 5, 2018. |
RX-119/18 | 2,731,620 | July 24, 2018 | July 25, 2019 |
RX-120/18 | 2,927,080 | August 28, 2018 | Missing fee and duplicate copy. |
RX-121/18 | 2,361,269 | October 22, 2018 | December 19, 2019 |
RX-122/18 | 2,753,156 | November 2, 2018 | September 18, 2020 |
RX-123/18 | 2,719,830 | December 7, 2018 | June 5, 2020 |
RX-124/19 | 2,491,858 | January 31, 2019 | Terminated. No substantial new question of patentability. Letter mailed June 3, 2019. |
RX-125/19 | 2,969,282 | February 4, 2019 | July 31, 2020 |
RX-126/19 | 2,600,265 | March 6, 2019 | October 5, 2020 |
RX-127/19 | 2,785,203 | April 12, 2019 | October 23, 2020 |
RX-128/19 | 2,855,060 | May 16, 2019 | January 18, 2023 |
RX-129/19 | 2,926,904 | May 17, 2019 | December 18, 2020 |
RX-130/19 | 2,702,437 | July 2, 2019 | Terminated. No substantial new question of patentability. Letter mailed October 24, 2019. |
RX-131/19 | 2,760,802 | September 23, 2019 | October 28, 2022 |
RX-132/19 | 2,686,159 | October 18, 2019 | July 3, 2020 |
RX-133/19 | 2,882,181 | October 31, 2019 | June 18, 2021 |
RX-134/19 | 2,829,473 | December 23, 2019 | October 9, 2020 |
RX-135/20 | 2,937,689 | January 2, 2020 | Terminated. No substantial new question of patentability. Letter mailed May 8, 2020. |
RX-136/20 | 2,906,217 | February 21, 2020 | Terminated. No substantial new question of patentability. Letter mailed August 11, 2020. |
RX-137/20 | 2,949,039 | February 26, 2020 | September 10, 2021 |
RX-138/20 | 2,770,216 | May 12, 2020 | Terminated. No substantial new question of patentability. Letter mailed October 9, 2020. |
RX-139/20 | 2,775,701 | June 2, 2020 | May 13, 2022 |
RX-140/20 | 2,957,167 | June 16, 2020 | Terminated. No substantial new question of patentability. Letter mailed September 25, 2020. |
RX-141/20 | 2,985,032 | August 7, 2020 | January 18, 2023 |
RX-142/20 | 2,508,258 | November 4, 2020 | December 17, 2021 |
RX-143/21 | 2,591,384 | January 28, 2021 | Terminated. No substantial new question of patentability. Letter mailed May 4, 2021. |
RX-144/21 | 2,838,151 | March 11, 2021 | Terminated. No substantial new question of patentability. Letter mailed July 8, 2021. |
RX-145/21 | 2,646,163 | March 31, 2021 | May 6, 2022 |
RX-146/21 | 3,070,751 | May 3, 2021 | Terminated. No substantial new question of patentability. Letter mailed August 26, 2021 |
RX-147/21 | 2,348,348 | May 28, 2021 | Terminated. No substantial new question of patentability. Letter mailed October 15, 2021. |
RX-148/21 | 1,341,519 | June 18, 2021 | Terminated. No substantial new question of patentability. Letter mailed November 4, 2021. |
RX-149/21 | 3,077,905 | September 16, 2021 | Terminated. No substantial new question of patentability. Letter mailed December 22, 2021. |
RX-150/21 | 2,871,354 | October 27, 2021 | September 22, 2023 |
RX-151/21 | 3,070,751 | October 28, 2021 | Terminated. No substantial new question of patentability. Letter mailed March 4, 2022. |
RX-152/22 | 2,737,094 | October 21, 2022 | June 28, 2023 |
RX-153/22 | 2,874,284 | November 24, 2022 | January 19, 2024 |
RX-154/23 | 2,842,822 | May 30, 2023 | Pending |
RX-155/23 | 3,079,619 | June 9, 2023 | April 3, 2024 |
RX-156/23 | 2,853,285 | September 12, 2023 | Terminated. No substantial new question of patentability. Letter mailed February 22, 2024. |
RX-157/23 | 3,180,537 | December 29, 2023 | Pending |